Keli Sensing holds 51% of the shares in Shenyang Dongda Sensing Company, and the enterprise search APP shows that recently, Shenyang Dongda Sensing Technology Co., Ltd. has undergone industrial and commercial changes, and the original shareholder Zhao Fu withdrew, adding Keli Sensing as the largest shareholder, holding 51%; At the same time, the company's key personnel have also changed, including Ke Jiandong as the new chairman and Wang Qiang as the company's manager, director and legal representative. Enterprise investigation shows that Shenyang Dongda Sensing Technology Co., Ltd. was established in March 1999, with Wang Qiang as the legal representative and a registered capital of 2 million yuan. It is mainly engaged in customized design, research and development of high-end temperature sensors and temperature measurement technical services.A number of private placements are optimistic about the market at the end of the year, and the two major directions are favored. Recently, A-shares have fluctuated, and the latest strategies of a number of first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Lei, deputy general manager and chief strategic investment official of Xingshi Investment, said that the current positive factors in the stock market are still accumulating, and the fundamentals, policies and funds are all supported. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. Judging from the specific optimistic investment direction at the end of the year, according to the comprehensive interview with private equity, consumption and technology are relatively more popular at present. (CSI Taurus)Chen Honghui, director of the Health and Health Commission of Hubei Province, is the new deputy secretary of Yichang Municipal Committee. According to the Three Gorges Daily in Yichang, Hubei Province, on December 10th, Yichang held a meeting of leading cadres in the whole city, and the organization department of Hubei Provincial Committee announced that Chen Honghui was appointed as a member, standing committee member and deputy secretary of CPC Yichang Municipal Committee. Previously, Chen Honghui served as Party Secretary and Director of Hubei Provincial Health and Wellness Committee.
The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.Microsoft has set up a new consumer artificial intelligence health department. According to the Financial Times, Microsoft has set up a consumer artificial intelligence health department in London, which will use generated AI to focus on consumer health applications, including specific health conditions, symptoms and mental health. Mustafa Suleyman, head of artificial intelligence at Microsoft, hired Dominic King, former head of DeepMind's health department.Wuxi factory was completed last year, and Yakult in Shanghai was closed this year: The Shanghai factory has been integrated into the Shanghai headquarters. Recently, the news that Yakult, a lactic acid bacteria brand, closed its Shanghai factory attracted attention. It is reported that the Shanghai factory producing Yakult, a lactic acid bacteria beverage, stopped production on December 6, and the production will be fully transferred to other domestic bases such as Tianjin factory and Wuxi factory. In this regard, Yakult China said that the Shanghai factory has been integrated into the Shanghai headquarters, and the closure of the Shanghai factory is part of the business reform, with the aim of improving production efficiency through restructuring and integrating resource allocation to further improve sales and performance. (21 Finance)
CICC: Xiamen Tungsten Industry will be successfully issued, and resource development and high-end production capacity construction are expected to accelerate. According to the research report of CICC, Xiamen Tungsten Industry (600549.SH) will be successfully issued, and resource development and high-end production capacity construction are expected to accelerate. It is worth noting that the final issue price of this fundraising is 20.80 yuan/share, which is 28.87% higher than the reserve price, and 3.35% lower than the closing price of 21.52 yuan/share on November 6, the first day of the issuance period. After the completion of the issuance, the company is expected to accelerate the development of tungsten resources and the construction of downstream high-end production capacity, and strengthen profit growth. Considering the impact of stock issuance, the net profit of returning to the mother in 2024 will remain unchanged at 1.92 billion yuan, and the net profit of returning to the mother in 2025 will be raised by 1.7% to 2.25 billion yuan, and CAGR+18.6% from 2023 to 2025. Raise the target price by 17% to 24.1 yuan.China, a huge Hong Kong stock market, once rose over 80%.Scott Richardson, Chief Operating Officer of Celanese, will be promoted to CEO. Celanese, a chemical company, announced on December 10th local time that Scott Richardson, the current Chief Operating Officer of Celanese, has been appointed as CEO since January 1st, 2025, and will join the board of directors of the company. Richardson will succeed Lori Ryerkerk, who will resign as president, CEO and Celanese director at the end of the year. Edward Galante has been elected as an independent director of Celanese since 2013, and he will be the chairman of Celanese board, which will take effect after Ryerkerk leaves office.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide